Long Term Follow up for the Detection of Delayed Adverse Events in Cal-1 Recipients

Long Term Follow-up for the Detection of Delayed Adverse Events in Recipients of CD4+ T Lymphocytes and/or CD34+ Hematopoietic Stem/Progenitor Cells Transduced With LVsh5/C46, a Dual Anti-HIV Gene Transfer Construct

Long term safety follow-up of Cal-1 recipients

Long Term Follow-up for the Detection of Delayed Adverse Events in Recipients of CD4+ T Lymphocytes and/or CD34+ Hematopoietic Stem/Progenitor Cells Transduced with LVsh5/C46 (Cal-1), a Dual Anti-HIV Gene Transfer Construct

Inclusion Criteria:

• Signed informed consent
• Previous treatment with the Cal-1 modified hematopoietic cellular products

Exclusion Criteria:

• Inability to understand and provide informed consent